Results 31 to 40 of about 6,563 (227)

Bisphosphonate-related osteonecrosis of the jaw: An enigma among medical practitioners

Indian Journal of Medical and Paediatric Oncology, 2019
Context: Owing to the increasing number of cancer cases, and introduction of newer drugs like bisphosphonates (BP) for the management of metastatic bone disease, complications such as bisphosphonate-related osteonecrosis of the jaw (BRONJ) have come into
Shalini Krishnan, Vijith Shetty, Jayarama Shetty, Gogineni Subhas Babu, T P Rajeev   +4 more
doaj   +1 more source

Knowledge of Brazilian dentists about bisphosphonate-associated osteonecrosis of the jaw

Brazilian Dental Science
Osteonecrosis of the jaw associated with bisphosphonate use is a matter of utmost importance in clinical practice for the safe treatment of patients using this medication.
Thainara Alexia Marinho de Souza , Gabriela Ribeiro Zucco, Janete Dias Almeida   +2 more
doaj   +1 more source

A maxillary reconstruction after osteonecrosis with surgical biomodels: A case report

Advances in Oral and Maxillofacial Surgery, 2021
Medication-related osteonecrosis of the jaw is a low prevalence condition in cancer patients which is mainly associated with bisphosphonates and other medication therapies, such as antiresorptive and antiangiogenic therapies.
Helena Polmann, Beatriz Helena Eger Schmitt, Roberta Aliny Santos Bendini, Pablo Cornelius Comelli Leite   +3 more
doaj   +1 more source

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis

, 2010
Bisphosphonates are the leading drugs for the treatment of osteoporosis. In ­randomized controlled trials (RCTs), alendronate, risedronate, and zoledronate have shown to reduce the risk of vertebral, nonvertebral, and hip fractures, whereas RCTs with ...
Graham Russell, Cooper, Cyrus, Ebetino, F. Hal, Cooper, C, Russell, RG, Pazianas, Michael, Ebetino, FH, Russell, R. Graham G., Pazianas, M   +8 more
core   +1 more source

Questionnaire about Occurrence and Condition of Bisphosphonate-Related Osteonecrosis of the Jaw [PDF]

, 2010
The purpose of this study was to survey the occurrence and condition of bisphosphonate-related osteonecrosis of the jaw (BRONJ). A questionnaire inquiring about clinical experience and the condition of patientswith BRONJ was sent to 11 departments of ...
鎌田, 孝広, 栗田, 浩, 盛岡, 昌史   +2 more
core   +1 more source

Bisphosphonate-associated jaw osteonecrosis in the treatment of rheumatoid arthritis [PDF]

RGO: Revista Gaúcha de Odontologia
This literature review aimed to raise the relationship between rheumatoid arthritis and mandibular osteonecrosis associated with bisphosphonates. The articles were collected in Pubmed, Bireme, Cochrane and Scielo between the years 2000 and 2023, the ...
Gabriela Dias Rosso dos Santos, Luciana Corrêa, Danielle Lima Corrêa de Carvalho   +2 more
doaj   +1 more source

The awareness and practice of dentists regarding medication-related osteonecrosis of the jaw and its prevention: a cross-sectional survey

BMC Oral Health, 2021
Background Accurate documentation of a patient’s prior medication use and awareness of side effects associated with anti-osteoporotic agents can assist dentists to prevent medication-related osteonecrosis of the jaw. I aimed to determine the awareness of
A. Lum Han
doaj   +1 more source

Histopathological assessment of the preventive effect of leukocyte-platelet-rich fibrin on bisphosphonate-related osteonecrosis of the jaw following dental extraction: An animal study

Heliyon, 2023
Background: Leukocyte- and platelet-rich fibrin (L-PRF) could be considered a preventive measure in Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ).
Milad Etemadi Sh, Farnaz Shooshtarian, Golnaz Tajmiri, MohammadSoroush Sehat   +3 more
doaj   +1 more source

Bisphosphonate associated osteomyelitis of the jaw in patients with bony exposure: prevention, a new way of thinking

Journal of Applied Oral Science, 2015
Objective There is strong evidence of a link between the use of systemic bisphosphonates (BPs) and osteonecrosis of the jaw, especially in cancer patients.
Arezo TARDAST, Reine SJÖMAN, Sigbjørn LØES, Jahan ABTAHI   +3 more
doaj   +1 more source

Intraosseous Squamous Cell Carcinoma Associated with Denosumab-Induced Osteonecrosis of the Jaw

, 2021
Medication-related osteonecrosis of the jaw (MRONJ) has been associated with the use of different drugs administered in the treatment of malignant neoplasms or metastases and in antiresorptive therapies. Since 2010, denosumab, a monoclonal antibody whose
Carlos Navarro Cuéllar, Zamorano León, José Javier, Rodríguez Pérez, Irene, Bacián Martínez, Sandra, Navarro Vila, Carlos, Ignacio Navarro Cuéllar, Edurne Palacios Weiss, José Luis del Castillo Pardo de Vera, García-Hidalgo Alonso, María Isabel, Amo Fernández de Velasco, Álvaro del, Pujol Romanyá, Roser, Margarita Escrig de Teijeiro, Palacios Weiss, Edurne, Navarro Cuéllar, Carlos, Álvaro del Amo Fernández de Velasco, María Isabel García-Hidalgo Alonso, Sandra Bacián Martínez, José J. Zamorano-León, López Farre, Antonio José, Arturo Sánchez-Pérez, Roser Pujol Romanyá, Antonio López-Farré, Navarro Cuéllar, Ignacio, Escrig de Teijeiro, Margarita, Sánchez-Pérez, Arturo, Irene Rodríguez Pérez, Castillo Pardo de Vera, José Luis del, Carlos Navarro Vila   +27 more
core   +1 more source